Translate Bio

Translate Bio is a biotechnology company located in Lexington, Massachusetts, in the United States. The company is associated with the development of messenger RNA (mRNA) therapeutics and vaccines, a field in which it has been recognized as a clinical-stage biopharmaceutical company. Its headquarters in Lexington places it within the Greater Boston life-sciences cluster, one of the world's densest concentrations of biotechnology research and development. As a biotech brand, Translate Bio's identity is tied to its scientific platform rather than to consumer products. The company has worked on mRNA-based approaches intended to instruct cells to produce therapeutic proteins, with research programs spanning infectious-disease vaccines and treatments for genetic disorders. This places it in the broader category of biotechnology companies developing novel modalities for medicine. The evidence available for this dossier is limited to basic identification: Wikidata records the entity as a company in Lexington, United States. Additional details such as founding year, founders, ownership structure, and listing status are not established by the supplied evidence and are therefore left unspecified here. The company's official website is translate.bio.

Translate Bio is a biotechnology company based in Lexington, Massachusetts, United States. The available evidence identifies it as a company in Lexington but does not provide a founding date, founding team, or detailed corporate history. The company is known in the biotechnology sector for its work on messenger RNA (mRNA) therapeutics and vaccines, a platform technology that became a major focus of the pharmaceutical industry in the 2010s and 2020s. Because the supplied evidence is limited to its identification as a Lexington-based company, this history section cannot responsibly include dated milestones, ownership changes, or product approvals without risking fabrication. What can be stated is that Translate Bio operates within the United States biotechnology industry, headquartered in the Greater Boston area, and is associated with the mRNA therapeutic field. Its official web presence is at translate.bio.

• 2021.09.14

  Reported2021.09.14

  Sanofi completes acquisition of Translate Bio[2]赛诺菲完成对Translate Bio的收购finanznachrichten.de

  Sanofi completed its acquisition of Translate Bio through a merger with a wholly owned Sanofi subsidiary. Translate Bio became an indirect, wholly owned subsidiary of Sanofi, and its shares were to cease trading on Nasdaq as of September 14, 2021.

• 2020.03.27

  Reported2020.03.27

  Sanofi Pasteur and Translate Bio partner on COVID-19 vaccine[3]赛诺菲巴斯德与Translate Bio合作开发新冠疫苗genengnews.com

  Sanofi Pasteur and Translate Bio announced a partnership to develop an mRNA vaccine to prevent COVID-19. The collaboration will apply Translate Bio’s mRNA platform and Sanofi Pasteur’s vaccine expertise to discover, design, and manufacture vaccine candidates.

Read more

1. 1Translate Bio (United States) - Wikidatawikidata.org
2. 2赛诺菲完成对Translate Bio的收购finanznachrichten.de
3. 3赛诺菲巴斯德与Translate Bio合作开发新冠疫苗genengnews.com